Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03738813
Other study ID # ICS Maugeri - CE 2208
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 1, 2018
Est. completion date September 7, 2021

Study information

Verified date September 2021
Source Istituti Clinici Scientifici Maugeri SpA
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Stroke is one of the leading causes of death and disability and has been described as a worldwide epidemic (1). Stroke survivors are affected by impairments and limitations of cognitive, language, perceptual, sensory, and motor functions. After a stroke, patients can improve spontaneously within the first 3 months (2) and then more slowly in the following year. The first day, decreased oedema and partial reperfusion of the ischemic penumbra may possibly explain these phenomena, but the improvement of neurological deficit in the following weeks suggests plasticity phenomena and brain cortical reorganization (3). While most recovery is thought to be made in the first few weeks after stroke, patients may make improvements on functional tasks many months after having a stroke (4). Restoring arm and hand skill after a stroke remains challenging, even though stroke rehabilitation programs have proven partial efficacy Repetitive task training has been shown to be effective in some aspects of rehabilitation, such as improving walking distance and speed and improving upper limb function (5). In this project, the investigators will use "Gloreha ARIA" (7) a new sensor-based therapy device designed for motor recovery of impaired upper limb Gloreha Aria offers specific programs that help patients to move arm, wrist and fingers. Therapists can customize therapy by focusing on a specific motor task.


Description:

The hypothesis was that rehabilitation with this device could be not inferior in comparison with hands-on physiotherapy, in the reeducation of upper arm in the patient affected by stroke from cerebral ischemia or hemorrhage that had occurred ≤ 30 days before. The principle purpose of this study will be to evaluate: 1. The feasibility of this new device 2. Efficacy in improving arm function abilities in the rehabilitation of patients with stroke in the sub-acute phase. Post-stroke patients admitted for inpatient rehabilitation to the Neurological Rehabilitation will be screened for enrolment and randomized in a controlled trial. All the patients will be informed about the aim and experimental procedures before enrolment, thus written informed consent will be obtained from all of them. Patients included in the study will be randomly assigned to intervention or control group according to simple randomization technique (computerized random numbers).


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date September 7, 2021
Est. primary completion date June 30, 2021
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - to exhibit first cerebral vascular disease with unilateral hemispherical lesion confirmed by CT scan or MRI; - to be sub-acute patients (less than 30 days from the cerebral vascular event); - being affected by upper limb paresis; Exclusion Criteria: 1. unable to understand verbal instruction or motor commands; 2. unilateral neglect; 3. apraxia; 4. significant visual impairment; 5. unstable medical condition; 6. significant orthopedic limitation to the shoulder, elbow; wrist and hand; 7. upper arm peripherical nerve lesion; 8. neuromuscular or neurodegenerative diseases; 9. spasticity > 3 in according to the Modifies Ashworth Scale (3);

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Gloreha Aria
Device offers specific programs that help patients to move arm, wrist and fingers
Other:
Usual care
Conventional occupational therapy

Locations

Country Name City State
Italy Istituti Clinici Scientifici Maugeri IRCCS Pavia

Sponsors (1)

Lead Sponsor Collaborator
Istituti Clinici Scientifici Maugeri SpA

Country where clinical trial is conducted

Italy, 

References & Publications (5)

Bennett DA, Krishnamurthi RV, Barker-Collo S, Forouzanfar MH, Naghavi M, Connor M, Lawes CM, Moran AE, Anderson LM, Roth GA, Mensah GA, Ezzati M, Murray CJ, Feigin VL; Global Burden of Diseases, Injuries, and Risk Factors 2010 Study Stroke Expert Group. The global burden of ischemic stroke: findings of the GBD 2010 study. Glob Heart. 2014 Mar;9(1):107-12. doi: 10.1016/j.gheart.2014.01.001. Review. — View Citation

Chen R, Cohen LG, Hallett M. Nervous system reorganization following injury. Neuroscience. 2002;111(4):761-73. Review. — View Citation

French B, Thomas LH, Coupe J, McMahon NE, Connell L, Harrison J, Sutton CJ, Tishkovskaya S, Watkins CL. Repetitive task training for improving functional ability after stroke. Cochrane Database Syst Rev. 2016 Nov 14;11:CD006073. Review. — View Citation

Maulden SA, Gassaway J, Horn SD, Smout RJ, DeJong G. Timing of initiation of rehabilitation after stroke. Arch Phys Med Rehabil. 2005 Dec;86(12 Suppl 2):S34-S40. — View Citation

Teasell RW, Murie Fernandez M, McIntyre A, Mehta S. Rethinking the continuum of stroke rehabilitation. Arch Phys Med Rehabil. 2014 Apr;95(4):595-6. doi: 10.1016/j.apmr.2013.11.014. Epub 2014 Feb 14. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Change from baseline of FMA-UE (Fugl-Meyer assessment upper extremity). Assessment of sensorimotor function. From date of randomization (T0) until the to the end of the study (T1) after an intervention lasting over a period of about 6 weeks, assessed after 30 rehabilitation sessions, lasting 30 min/ day each and performed 5 days/week.
See also
  Status Clinical Trial Phase
Completed NCT05691673 - Upper Extremity Force-velocity Profile in Swimmers
Completed NCT03677778 - Interscalene Brachial Plexus Block Washout to Reverse Inadvertent Phrenic Nerve Blockade N/A
Recruiting NCT04501510 - Ultrasonography in Fracture Management
Not yet recruiting NCT06356415 - Infraclavicular Brachial Plexus Block With Bupivacaine Alone or With Both Dexmedetomidine and Dexamethasone N/A
Completed NCT05359731 - Pharmacokinetic Analysis of Bupivacaine in the Presence and Absence of Perineural Dexamethasone in Axillary Blockade Phase 4
Completed NCT03807505 - Erector Spinae Plane Versus Interscalene Blocks for Shoulder Surgery N/A
Recruiting NCT03595514 - Single Versus Double Injection Costoclavicular Block N/A
Withdrawn NCT01605929 - Clinical Evaluation of the Ultrasound-Guided Retroclavicular Brachial Plexus Block N/A
Recruiting NCT04994405 - Lower Tourniquet Pressure Study N/A
Completed NCT04019990 - Throwers Ten Exercises On Upper Extremity Function and Explosive Power in Wheelchair Basketball and Basketball Players N/A
Recruiting NCT03702387 - Evaluation of Second Esmarch Application on Intravenous Regional Anesthesia Effectiveness N/A
Recruiting NCT05261425 - Suture Closure Trial N/A
Completed NCT05476198 - Brachial Plexus Block vs. General Anesthesia for Anesthesia Anxiety Before Orthopedic Upper Extremity Surgery N/A
Completed NCT05422989 - Public Health Risks and Characteristics of Upper Extremity Trauma During COVID-19
Recruiting NCT06016647 - Multi-axis Assessment of Injured Workers
Completed NCT04875039 - Dexametasone Versus Dexametasone Plus Dexmedetomidine in Nerve Blocks Phase 4
Completed NCT03610893 - Dexamethasone Versus Dexmedetomidine as Adjuvants for Nerve Blocks N/A
Enrolling by invitation NCT05328934 - SoftHand Comparison Study N/A